Tech Company Financing Transactions
Akamis Bio Funding Round
On 12/17/2024, Akamis Bio announced $60 million in funding from Sedgwick Yard and private investors.
Transaction Overview
Company Name
Announced On
12/17/2024
Transaction Type
Venture Equity
Amount
$60,000,000
Round
Undisclosed
Investors
Sedgwick Yard (Lead Investor)
Proceeds Purpose
The company intends to use the funds to support its work to advance NG-350A through a Phase 1b clinical proof-of-concept (PoC) study in patients with locally advanced rectal cancer (LARC).
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
Undisclosed
Cambridge, MA Undisclosed
USA
Cambridge, MA Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Akamis Bio, a Cambridge, MA-based clinical-stage oncology company.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Howard Davis
Browse more venture capital transactions:
Prev: 12/17/2024: Landbase venture capital transaction
Next: 12/17/2024: Volume venture capital transaction
Share this article
News on VC Transactions
We do our best to record funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs